文献速递技术与安全

第20届格雷讲座2019:健康与重离子

The 20th Gray lecture 2019: health and heavy ions.
PubMed 文献 · Br J Radiol · 2020-10-06

1954至2019年间全球约250,000例患者接受带电粒子放疗(强子治疗)治疗癌症或脑动静脉畸形等其他病变。

要点

  • 1954至2019年全球约25万例患者接受带电粒子放疗,质子束213,000例,碳离子束约32,000例。
  • 当前82家离子束临床治疗机构中,仅13家位于亚洲和欧洲提供碳离子束用于临床及太空研究。
  • 带电粒子治疗可靶向杀伤肿瘤并保护正常组织,但仍需进一步优化和技术改进以降低成本。

诊断标准与关键数值

  • 1954至2019年间全球约250,000例患者接受带电粒子放疗(强子治疗)治疗癌症或脑动静脉畸形等其他病变。
  • 其中大多数患者(213,000例)接受质子束治疗,约32,000例接受碳离子放疗。
  • 有3,500例患者接受氦、π介子、氖或其他离子治疗。
  • 目前有82家机构开展离子束临床治疗,其中仅13家位于亚洲和欧洲提供碳离子束用于临床前、临床和太空研究。
  • 约550余人曾进入低地球轨道及更远太空并返回地球。

临床应用与阅片要点

  • 作者认为带电粒子治疗仍需进一步优化和技术改进以降低成本,但应让全世界有需要的人都能获得。
  • 作者指出需要更多针对银河宇宙辐射场成分的基础研究,以确保太空辐射及微重力联合应激源在探索性深空旅行中的安全性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Particle radiobiology has contributed new understanding of radiation safety and underlying mechanisms of action to radiation oncology for the treatment of cancer, and to planning of radiation protection for space travel. This manuscript will highlight the significance of precise physical and biologically effective dosimetry to this translational research for the benefit of human health.This review provides a brief snapshot of the evolving scientific basis for, and the complex current global status, and remaining challenges of hadron therapy for the treatment of cancer. The need for particle radiobiology for risk planning in return missions to the Moon, and exploratory deep-space missions to Mars and beyond are also discussed.

METHODS: Key lessons learned are summarized from an impressive collective literature published by an international cadre of multidisciplinary experts in particle physics, radiation chemistry, medical physics of imaging and treatment planning, molecular, cellular, tissue radiobiology, biology of microgravity and other stressors, theoretical modeling of biophysical data, and clinical results with accelerator-produced particle beams.

RESULTS: Research pioneers, many of whom were Nobel laureates, led the world in the discovery of ionizing radiations originating from the Earth and the Cosmos. Six radiation pioneers led the way to hadron therapy and the study of charged particles encountered in outer space travel. Worldwide about 250,000 patients have been treated for cancer, or other lesions such as arteriovenous malformations in the brain between 1954 and 2019 with charged particle radiotherapy, also known as hadron therapy. The majority of these patients (213,000) were treated with proton beams, but approximately 32,000 were treated with carbon ion radiotherapy. There are 3500 patients who have been treated with helium, pions, neon or other ions. There are currently 82 facilities operating to provide ion beam clinical treatments. Of these, only 13 facilities located in Asia and Europe are providing carbon ion beams for preclinical, clinical, and space research. There are also numerous particle physics accelerators worldwide capable of producing ion beams for research, but not currently focused on treating patients with ion beam therapy but are potentially available for preclinical and space research. Approximately, more than 550 individuals have traveled into Lower Earth Orbit (LEO) and beyond and returned to Earth.

CONCLUSION: Charged particle therapy with controlled beams of protons and carbon ions have significantly impacted targeted cancer therapy, eradicated tumors while sparing normal tissue toxicities, and reduced human suffering. These modalities still require further optimization and technical refinements to reduce cost but should be made available to everyone in need worldwide. The exploration of our Universe in space travel poses the potential risk of exposure to uncontrolled charged particles. However, approaches to shield and provide countermeasures to these potential radiation hazards in LEO have allowed an amazing number of discoveries currently without significant life-threatening medical consequences. More basic research with components of the Galactic Cosmic Radiation field are still required to assure safety involving space radiations and combined stressors with microgravity for exploratory deep space travel.

ADVANCES IN KNOWLEDGE: The collective knowledge garnered from the wealth of available published evidence obtained prior to particle radiation therapy, or to space flight, and the additional data gleaned from implementing both endeavors has provided many opportunities for heavy ions to promote human health.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Blakely EA. The 20th Gray lecture 2019: health and heavy ions. Br J Radiol. 2020. PMID: 33021811. doi:10.1259/bjr.20200172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。